📣 VC round data is live. Check it out!

L'Oreal Valuation Multiples

Discover revenue and EBITDA valuation multiples for L'Oreal and similar public comparables like Novo Nordisk, Unilever, Procter & Gamble, EssilorLuxottica and more.

L'Oreal Overview

About L'Oreal

L’Oréal is the largest beauty product maker in the world, participating in categories including skin care (39% of sales), makeup (19%), hair care (24%), fragrance (14%), and sanitary products (4%). The firm also has a diversified geographic footprint, generating 33% of sales in Europe, 27% from North America, 24% in North Asia, and the rest from various emerging markets across South Asia, Latin America, and Africa. L’Oréal owns a mix of premium and mass beauty brands sold through a wide range of channels such as mass retail, drugstores, department stores, travel retail, e-commerce, hair salons, and medi-spas. Leading brands include Lancôme, Yves Saint Laurent, Maybelline, Kiehl’s, L’Oréal Paris, Kerastase, CeraVe, Garnier, and Armani.


Founded

1909

HQ

France

Employees

94.4K

Website

loreal.com

Financials (LTM)

Revenue: $53B
EBITDA: $13B

EV

$224B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

L'Oreal Financials

L'Oreal reported last 12-month revenue of $53B and EBITDA of $13B.

In the same LTM period, L'Oreal generated $39B in gross profit, $13B in EBITDA, and $8B in net income.

Revenue (LTM)


L'Oreal P&L

In the most recent fiscal year, L'Oreal reported revenue of $52B and EBITDA of $12B.

L'Oreal is profitable as of last fiscal year, with gross margin of 73%, EBITDA margin of 24%, and net margin of 15%.

See analyst estimates for L'Oreal
LTMLast FY202320242025202620272028
Revenue$53B$52B$48B$51B$51B
Gross Profit$39B$38B$35B$37B$38B
Gross Margin74%73%74%74%74%
EBITDA$13B$12B$12B$12B$12B
EBITDA Margin24%24%24%25%24%
EBIT Margin20%20%20%20%20%
Net Profit$8B$8B$7B$7B$7B
Net Margin16%15%15%15%14%
Net Debt—$295M———

Financial data powered by Morningstar, Inc.

L'Oreal Stock Performance

L'Oreal has current market cap of $221B, and enterprise value of $224B.

Market Cap Evolution


L'Oreal's stock price is $414.75.

L'Oreal share price decreased by 3.0% in the last 30 days, and by 3.5% in the last year.

L'Oreal has an EPS (earnings per share) of $15.11.

See more trading valuation data for L'Oreal
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$224B$221B-0.1%-3.0%-11.6%-3.5%$15.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

L'Oreal Valuation Multiples

L'Oreal trades at 4.2x EV/Revenue multiple, and 17.7x EV/EBITDA.

See NTM and 2027E valuation multiples for L'Oreal

EV / Revenue (LTM)


L'Oreal Financial Valuation Multiples

As of May 19, 2026, L'Oreal has market cap of $221B and EV of $224B.

L'Oreal has a P/E ratio of 26.9x.

LTMLast FY202320242025202620272028
EV/Revenue4.2x4.3x4.7x4.4x4.4x
EV/EBITDA17.7x18.0x19.4x18.0x18.0x
EV/EBIT21.0x21.4x23.7x22.2x21.7x
EV/Gross Profit5.7x5.9x6.3x6.0x5.9x
P/E26.9x27.4x30.8x29.7x31.1x
EV/FCF25.3x25.0x31.5x29.0x26.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified L'Oreal Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

L'Oreal Margins & Growth Rates

L'Oreal grew revenue by 3% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, L'Oreal reported gross margin of 73%, EBITDA margin of 24%, and net margin of 15%.

See estimated margins and future growth rates for L'Oreal

L'Oreal Margins

Last FY202420252026202720282029
Gross Margin73%74%74%74%
EBITDA Margin24%25%24%24%
EBIT Margin20%20%20%20%
Net Margin15%15%14%16%
FCF Margin17%15%16%16%

L'Oreal Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth3%6%1%5%
Gross Profit Growth5%6%1%5%
EBITDA Growth5%7%0%5%
EBIT Growth5%7%2%6%
Net Profit Growth5%4%(4%)19%
FCF Growth(3%)9%8%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

L'Oreal Operational KPIs

L'Oreal's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.

L'Oreal's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

L'Oreal's Rule of X is 37% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for L'Oreal
LTMLast FY202320242025202620272028
Rule of 4028%29%———
Bessemer Rule of X34%37%———
Revenue per Employee—$0.6M———
Opex per Employee—$0.3M———
S&M Expenses to Revenue32%32%32%32%32%
G&A Expenses to Revenue19%19%19%19%19%
R&D Expenses to Revenue3%3%3%3%3%
Opex to Revenue—53%54%54%54%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

L'Oreal Competitors

L'Oreal competitors include Novo Nordisk, Unilever, Procter & Gamble, EssilorLuxottica, AbbVie, Colgate-Palmolive, Hindustan Unilever, Galderma, Bayer and Haleon.

Most L'Oreal public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Novo Nordisk4.6x4.8x9.3x9.9x
Unilever2.5x2.5x10.9x10.9x
Procter & Gamble4.2x4.1x14.9x15.1x
EssilorLuxottica3.1x3.0x12.9x12.6x
AbbVie7.1x6.8x17.9x15.9x
Colgate-Palmolive3.9x3.8x15.8x15.7x
Hindustan Unilever8.2x8.1x33.3x34.3x
Galderma9.1x8.5x39.3x34.8x

This data is available for Pro users. Sign up to see all L'Oreal competitors and their valuation data.

Start Free Trial

L'Oreal M&A Activity

L'Oreal has acquired 26 companies to date.

Last acquisition by L'Oreal was on October 19th 2025. L'Oreal acquired Creed for $3B (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by L'Oreal

Creed
Color Wow
Medik8
Dr.G
Description
Creed is a London-headquartered luxury fragrance house founded in 1760, crafting bespoke scents from Grasse, France. Bestsellers like Aventus for men and Fleurissimo for women use ingredients such as ginger and pink pepper. The brand supplies bath gels, lotions, and candles to 50 countries, with Aqua Fiorentina lotion featuring violet and citrus notes. Worn by royals and celebrities, Creed generates over €100 million in sales annually.
Color Wow is a hair care brand offering products for color-treated and damaged hair, including Dream Coat anti-frizz spray, Pop & Lock curl enhancer, and Xtra Large shampoo. Distributed through salons and retailers worldwide, it focuses on salon-quality formulas that extend color vibrancy and manage texture without sulfates or silicones. The brand maintains a presence in professional and consumer markets via its U.S.-based operations.
Medik8 is a London-headquartered skincare manufacturer specializing in vitamin C serums, copper peptide creams, and crystal retinal exfoliants sold via dermatologists and online. The brand's Surface Radiance Cleanse and Barrier Restore Cream feature stabilized actives tested in UK labs for tolerability. Founded in 2010, Medik8 distributes to 40 countries through Dermstore and maintains production in Hertfordshire with a focus on time-released delivery systems.
Dr.G is a Seoul-based skincare brand and e-commerce platform selling cosmetics tailored for sensitive and troubled skin. Key products include Red Blemish Clear Soothing Cream, Green Gram Cleansing Oil, and Pore Control Serum, all dermatologist-tested and free of irritants. Established in 2014, it distributes through retailers like Olive Young and international platforms, gaining traction in the K-beauty sector for acne treatment and hydration formulas.
HQ CountryUnited KingdomUnited StatesUnited KingdomSouth Korea
HQ City
London
Norwalk, CT
London
Seongnam
Deal Date19 Oct 202530 Jun 20259 Jun 202523 Dec 2024
Valuation$3B$1B$2B$707M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all L'Oreal acquisitions and their M&A valuation multiples.

Start Free Trial

L'Oreal Investment Activity

L'Oreal has invested in 10 companies to date.

Latest investment by L'Oreal was on December 8th 2025. L'Oreal invested in Galderma in their $5B Secondary - public round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by L'Oreal

Galderma
Chando
Mahta.bio
Sparxell
Description
Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs around 7,00 people.
Chando is a Shanghai-based skincare brand that creates facial masks, serums, and creams using Himalayan glacial water, peony extracts, and biotechnology processes adapted for Chinese skin concerns like sensitivity and pigmentation.
Mahta.bio is a San Francisco-based food and beverage company developing functional beverages infused with adaptogenic mushrooms targeting wellness markets in North America.
Sparxell is a French nanotechnology company that produces photonic pigments mimicking structural colors found in nature, such as butterfly wings and peacock feathers. These pigments enable brilliant, angle-dependent hues without heavy metals for applications in automotive coatings, cosmetics, and plastics. Sparxell's products include Sparxel Supreme and Classic lines, partnered with BASF for global distribution since its founding in 2019 in Bordeaux.
HQ CountrySwitzerlandChinaBrazilUnited Kingdom
HQ City
Lausanne
Shanghai
SĂŁo Paulo
Cambridge
Deal Date8 Dec 20259 Oct 202519 Aug 20252 Apr 2024
RoundSecondary - publicUndisclosed stageSeedSeed
Raised$5B$104M$4M$3M
InvestorsL'OrealHarvest Capital; L'OrealASN Bank; CGIAR Consortium; Impact Earth; L'Oreal; Soros Economic Development Fund; The Brazilian Development Bank(BNDES)Circular Innovation Fund; Earth Venture Capital; Future Communities Capital; Granatus Ventures; Joyance Partners; Katapult; L'Oreal; PDS Ventures; Snøcap
Valuation$49B$1Bundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all L'Oreal investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About L'Oreal

When was L'Oreal founded?L'Oreal was founded in 1909.
Where is L'Oreal headquartered?L'Oreal is headquartered in France.
How many employees does L'Oreal have?As of today, L'Oreal has over 94K employees.
Who is the CEO of L'Oreal?L'Oreal's CEO is Nicolas Hieronimus.
Is L'Oreal publicly listed?Yes, L'Oreal is a public company listed on Euronext Paris.
What is the stock symbol of L'Oreal?L'Oreal trades under OR ticker.
When did L'Oreal go public?L'Oreal went public in 1989.
Who are competitors of L'Oreal?L'Oreal main competitors include Novo Nordisk, Unilever, Procter & Gamble, EssilorLuxottica, AbbVie, Colgate-Palmolive, Hindustan Unilever, Galderma, Bayer, Haleon.
What is the current market cap of L'Oreal?L'Oreal's current market cap is $221B.
What is the current revenue of L'Oreal?L'Oreal's last 12 months revenue is $53B.
What is the current revenue growth of L'Oreal?L'Oreal revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of L'Oreal?Current revenue multiple of L'Oreal is 4.2x.
Is L'Oreal profitable?Yes, L'Oreal is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of L'Oreal?L'Oreal's last 12 months EBITDA is $13B.
What is L'Oreal's EBITDA margin?L'Oreal's last 12 months EBITDA margin is 24%.
What is the current EV/EBITDA multiple of L'Oreal?Current EBITDA multiple of L'Oreal is 17.7x.
What is the current FCF of L'Oreal?L'Oreal's last 12 months FCF is $9B.
What is L'Oreal's FCF margin?L'Oreal's last 12 months FCF margin is 17%.
What is the current EV/FCF multiple of L'Oreal?Current FCF multiple of L'Oreal is 25.3x.
How many companies L'Oreal has acquired to date?As of May 2026, L'Oreal has acquired 26 companies.
What was the largest acquisition by L'Oreal?$3B acquisition of Creed on 19th October 2025 was the largest M&A L'Oreal has done to date.
What companies L'Oreal acquired?L'Oreal acquired Creed, Aesop, Medik8, CeraVe, IT Cosmetics, Color Wow, Dr.G, NYX Cosmetics, Pulp Riot, Thayers Natural Remedies, and 16 other companies.
In how many companies L'Oreal has invested to date?As of May 2026, L'Oreal has invested in 10 companies.
What was the last L'Oreal investment?On 8th December 2025 L'Oreal invested in Galderma, participating in a $5B Secondary - public round at $49B valuation.
In what companies L'Oreal invested in?L'Oreal invested in Galderma, Chando, NetZero, BeautyCon, Digital Village, Mahta.bio, Rize ag, Sparxell, Poplar Studio, and The Sabi.

See public comps similar to L'Oreal

Lists including L'Oreal

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial